View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 23, 2022

Nvidia introduces Clara Holoscan MGX for medical device industry

The new computing platform processes high-throughput data streams for real-time insights.

Nvidia has launched a new artificial intelligence (AI) computing platform, Clara Holoscan MGX, for medical devices and computational sensing systems.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new platform supports the development of medical devices from clinical trials to commercial deployment of real-time AI applications at the edge.

By expanding the Clara Holoscan platform, it provides medical-grade reference architecture and long-term software support to expedite medical device industry innovations.

Clara Holoscan MGX processes high-throughput data streams for real-time insights.  

It combines the NVIDIA Jetson AGX Orin Industrial module, NVIDIA RTX A6000 GPU and NVIDIA ConnectX-7 SmartNIC network adapter into a scalable AI platform.

Nvidia healthcare vice-president Kimberly Powell said: “Deploying real-time AI in healthcare and life sciences is critical to enable the next frontiers in surgery, diagnostics and drug discovery.

“Clara Holoscan MGX, with its unique combination of AI, accelerated computing and advanced visualisation, accelerates the productisation of AI and provides software-as-a-service business models for the medical device industry.”

Hardware reference design with long-life components and ten-year long-term software support are included as part of Clara Holoscan MGX.

The company also provides IEC62304 documentation for software and IEC60601 attestation reports from embedded computing partners.

Nvidia noted that Dedicated Computing, MBX Systems, Prodrive Technologies, ADLINK, Advantech, Kontron, Leadtek, Onyx Healthcare, Portwell, RYOYO Electro and Yuan High-Tech will be the first embedded-computing manufacturers to develop medical products based on the new platform reference design.

In 2019, the company collaborated with the American College of Radiology (ACR) to provide an open AI platform for diagnostic algorithms’ development.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network